Marketing & Strategy
PRIME Awards 2020 call for entries – deadline extended
Marketing & Strategy: The PRIME Awards, the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries with key dates below.
Chair of Judges, Mr David Cousins, returns to oversee and facilitate judging, which this year broadens the review process with a mix of new and returning judges, all highly experienced in their field.
“I’m excited to follow up on the success of 2019 where we had our biggest year ever. To continue to ensure that the highest calibre of work is recognised, in 2020 we have evolved the judging process to a two-stage approach and welcomed new judges,” said Mr Cousins.
In light of the current COVID-19 restrictions, a decision will be made closer to the time regarding the format of the awards ceremony.
“Whilst the current situation is making the future seem uncertain, the PRIME Awards gives us time to reflect on our hard work and ultimately celebrate success – no matter what medium the awards ceremony may be held in” said Mr Cousins.
“Pausing to recognise innovation, collaboration and success in our industry is critical to increasing knowledge and skill as a whole.”
KEY INFORMATION
Entries Open Now and Close
Thursday 25th June
Finalists Announced
Early August
Awards Ceremony
Thursday 24th September
There are 18 categories for teams and individuals within the pharmaceutical and life sciences industry to shine. Full details of the categories and the entry kit can be found at www.primeawards.com.au
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More